BMC Cancer

official impact factor 3.15

Open Access Pre-publication history

Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26)

Dirk Vordermark*, Klemens Ruprecht, Peter Rieckmann, Wolfgang Roggendorf, Giles H Vince, Monika Warmuth-Metz, Oliver Kölbl and Michael Flentje

BMC Cancer 2006, 6:247 doi:10.1186/1471-2407-6-247

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 16 Mar 2006
Reviewer's Report Henry Friedman 07 Apr 2006
Reviewer's Report Jerome Posner 16 Apr 2006
Resubmission - Version 3 Manuscript Author's comment 28 Sep 2006
Resubmission - Version 4 Manuscript Author's comment 16 Oct 2006
Editorial acceptance 17 Oct 2006
Published 18 Oct 2006